Department of Hematology, Guangdong Second Provincial General Hospital
Department of Hematology, Guangdong Second Provincial General Hospital
Guangzhou, Guangdong, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chidamide in HR-AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Not stated | 2026-09-16 | NCT07822789 | |
| Luspatercept for CIA in AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-06-23 | NCT07663864 | |
| VEN+IDAC vs IDAC in AML | Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Enrolling by invitation | Phase 2 / Phase 3 | 2026-04-17 | NCT07537257 | |
| HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL). | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Enrolling by invitation | Phase 2 | 2026-04-08 | NCT07517510 |